Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Daliborka Bursac"'
Autor:
Tomi Kovacevic, Bojan Zaric, Jelena Djekic Malbasa, Darijo Bokan, Borislava Nikolin, Daliborka Bursac, Petar Simurdic, Vladimir Stojsic, Goran Stojanovic, Dragana Maric
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3350-3360 (2024)
Background and Objectives: Death is an unavoidable experience in any person’s life and affects not only the dying person but also their caregivers. The dying process has been displaced from homes to health care facilities in the majority of cases.
Externí odkaz:
https://doaj.org/article/f2cc28b50e8546209dea2b7d139128c3
Autor:
Daliborka Bursac, Bojan Zarić, Tomi Kovačević, Vladimir Stojšić, Anastasios Vagionas, Ioannis Boukovinas, Kosmas Tsakiridis, Christoforos Kosmidis, Konstantinos Sapalidis, Konstantinos Romanidis, Nikolaos Courcoutsakis, Dimitris Matthaios, Paul Zarogoulidis, Chrysanthi Sardeli, Vanesa Sekerus
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 716-724 (2021)
Traditionally, tissue availability from rebiopsy is a prerequisite for adequate sequencing of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in therapy for advanced-stage lung cancer. Tissue biopsy truly is the gold standard
Externí odkaz:
https://doaj.org/article/f345fecc4a12422d8fd4ac6c820843ba
Autor:
Daliborka Bursac, Bojan Zaric, Darijo Bokan, Tomi Kovacevic, Vladimir Stojsic, Svetlana Petkov, Kosana Mitrovic, Goran Stojanovic
Publikováno v:
Vojnosanitetski pregled. 79:481-487
Background/Aim. The coronavirus disease 2019 (COVID-19) pandemic has multiple impacts on the management of cancer patients. Treatment of malignancies, including chemotherapy, targeted therapy, immunotherapy, and radiotherapy, can suppress the immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c7b73bbc392fb751aea49ac44f953d0
https://doi.org/10.2298/vsp211120018b
https://doi.org/10.2298/vsp211120018b
Autor:
Konstantinos Sapalidis, Dimitris Matthaios, Chrysanthi Sardeli, Nikolaos Courcoutsakis, Paul Zarogoulidis, Tomi Kovacevic, Konstantinos Romanidis, Christoforos Kosmidis, Bojan Zaric, Daliborka Bursac, Anastasios Vagionas, Vanesa Sekeruš, Ioannis Boukovinas, Vladimir Stojsic, Kosmas Tsakiridis
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 2, Pp 716-724 (2021)
Case Reports in Oncology, Vol 14, Iss 2, Pp 716-724 (2021)
Traditionally, tissue availability from rebiopsy is a prerequisite for adequate sequencing of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in therapy for advanced-stage lung cancer. Tissue biopsy truly is the gold standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7358ac4e1482824fc529dce07a183fa6
https://doi.org/10.1159/000515506
https://doi.org/10.1159/000515506
Autor:
Chong Bai, Tomi Kovacevic, Tatjana Sarcev, Otelia Rogoveanu, Christoforos Kosmidis, Konstantinos Sapalidis, Kosmas Tsakiridis, Konstantinos Romanidis, Xiaping Shen, Maria Kosmidou, Haidong Huang, Aris Ioannidis, Ion Rogoveanu, Wolfgang Hohenforst-Schmidt, Savas Petanidis, Jiannan Wang, Aggeliki Rapti, Sofia Baka, Stelian Pantea, Yunye Ning, Bojan Zaric, Jun Zhou, Meng Yang, Biljana Kukic, Zhiang Huang, Daliborka Bursac, Dimitris Petridis, Rong Zhang, Anastasios Vagionas, Paul Zarogoulidis, Issak Kesisoglou, Vladimir Stojsic
Publikováno v:
Expert Review of Medical Devices. 18:197-201
Thyroid cancer is usually diagnosed both with imaging techniques and transdermal biopsy. Laboratory tests are also included in the initial work-up.One hundred and thirty patients were included in our study with pathological imaging findings in the th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398cd938b31ad1d73679396f7aebe100
https://doi.org/10.1080/17434440.2021.1880891
https://doi.org/10.1080/17434440.2021.1880891
Autor:
Tomi Kovacevic, Jun Zhou, Ying Xia, Konstantinos Drevelegas, Konstantinos Romanidis, Chong Bai, Yinfeng Ding, Bojan Zaric, Aris Ioannidis, Evagelia Athanasiou, Ioannis Boukovinas, Chrysanthi Sardeli, Daliborka Bursac, Lutz Freitag, Nikolaos Barbetakis, Wang Xiangqi, Tatjana Sarcev, Christoforos Kosmidis, Konstantinos Sapalidis, Dimitris Paliouras, Anastasios Vagionas, Vladimir Stojsic, Paul Zarogoulidis, Biljana Kukic, Dimitris Petridis, Qin Wang, Wolfgang Hohenforst-Schmidt, Sofia Baka, Dimitris Drougas, Chrisanthi Karapantzou, Electra Michalopoulou-Manoloutsiou, Savvas Petanidis, Kosmas Tsakiridis, Aimilios Lallas, Dimitris Matthaios, Haidong Huang, Dimitrios Hatzibougias
Publikováno v:
Journal of Cancer
Introduction: Immunotherapy is being used for the past five years either as first line or second line treatment with great results. Chemotherapy and radiotherapy have been also used as combination to immunotherapy to further enhance this type of trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333658a6db2c0f8b134bdbf246f75d60
https://doi.org/10.7150/jca.55322
https://doi.org/10.7150/jca.55322
Autor:
Kosmas Tsakiridis, Wolfgang Hohenforst-Schmidt, Sofia Baka, Chriforos Kosmidis, Ioannis Boukovinas, Savvas Petanidis, Bojan Zaric, Vladimir Stojsic, Vagelis Christakidis, Paul Zarogoulidis, Haidong Huang, Tatjana Sarcev, Christos Tolis, Anastasios Vagionas, Daliborka Bursac, Konstantinos Sapalidis, Dimitris Petridis, Eleni-Isidora Perdikouri, Biljana Kukic, Konstantinos Romanidis, Tomi Kovacevic, Chrysanthi Sardeli
Publikováno v:
Expert Review of Respiratory Medicine. 15:675-679
Objectives Lung cancer is still diagnosed at advanced stage and early treatment initiation is needed. Therefore, we need biomarkers or clusters of information that can provide early treatment prognosis. Methods Biopsies were acquired from 471 patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a1d9a2698f5b51091d58c6366947e01
https://doi.org/10.1080/17476348.2021.1859373
https://doi.org/10.1080/17476348.2021.1859373
Autor:
Daliborka, Bursac, Dimitris, Petridis, Bojan, Zaric, Tomi, Kovacevic, Vladimir, Stojsic, Tatjana, Sarcev, Haidong, Huang, Chong, Bai, Wolfgang, Hohenforst-Schmidt, Christoforos, Kosmidis, Konstantinos, Sapalidis, Konstantinos, Romanidis, Nikolaos, Courcoutsakis, Aimilios, Lallas, Giorgos, Tsakaldimis, Kyriakoula, Chatzimichael, Chrysanthi, Sardeli, Dimitris, Matthaios, Paul, Zarogoulidis, Chrysanthi, Karapantzou
Publikováno v:
Current health sciences journal. 47(4)
The first wave of the COVID-19 pandemic initiated officially in October 2020. Since then several observations have been made regarding the disease and its symptoms.We included eighty seven in our observational study. Our main aim was to investigate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b161154c32a6b72351dd3b70e667ebf7
https://pubmed.ncbi.nlm.nih.gov/35444815
https://pubmed.ncbi.nlm.nih.gov/35444815
Autor:
Nensi Lalić, Marko Bojović, Daliborka Bursać, Darijo Bokan, Vesna Čeriman Krstić, Ivan Kuhajda, Biljana Parapid, Sanja Tomić, Aleksandar Šipka
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
Background: By 2021, the FDA approved the use of the drugs pembrolizumab and atezolizumab in the first-line treatment of patients with high positivity of programmed death ligand-1 (PD-L1) in locally advanced and metastatic non-small-cell-lung cancer
Externí odkaz:
https://doaj.org/article/95756b641aff45ff80ea0ee90ab3c859
Autor:
Sofia Baka, Savas Petanidis, Haidong Huang, Branislav Perin, Christoforos Kosmidis, Konstantinos Romanidis, Nikolaos Courcoutsakis, Dimitrios Hatzibougias, Maria Kosmidou, Bojan Zaric, Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Kosmas Tsakiridis, Tatjana Sarcev, Vasiliki Theofilatou, Biljana Kukic, Evagelia Athanasiou, Chong Bai, Lutz Freitag, Konstantinos Sapalidis, Konstantinos Drevelegas, Eleni-Isidora Perdikouri, Dimitris Drougas, Daliborka Bursac, Tomi Kovacevic, Ioannis Boukovinas, Vladimir Stojsic, Anastasios Vagionas, Dimitris Petridis
Publikováno v:
Journal of Cancer
Introduction: Novel technologies are currently used for lung cancer diagnosis. EBUS-TBNA 22G is considered one of the most important tools. However; there are still issues with the sample size.Patients and Methods: 223 patients underwent EBUS-TBNA wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bee910c90d0c47153b43d47daa84b50b
https://pubmed.ncbi.nlm.nih.gov/33033529
https://pubmed.ncbi.nlm.nih.gov/33033529